Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study (Q40342526)

19 September 2017

title

Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study (English)

1 reference

19 September 2017

1 reference

6

1 reference

19 September 2017

Santtu Heinonen

1

0 references

Thedi Ziegler

series ordinal

5

object named as

Thedi Ziegler

1 reference

19 September 2017

Heli Silvennoinen

2

1 reference

19 September 2017

Pasi Lehtinen

series ordinal

3

1 reference

19 September 2017

Raija Vainionpää

series ordinal

4

1 reference

19 September 2017

publication date

22 November 2010

1 reference

Lancet Infectious Diseases

19 September 2017

published in

1 reference

19 September 2017

volume

11

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

23-29

1 reference

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Influenza and the rates of hospitalization for respiratory disease among infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Burden of influenza in children in the community

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

The underrecognized burden of influenza in young children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Cost-effectiveness of influenza vaccination of healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Vaccines for preventing influenza in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

One-incubation time-resolved fluoroimmunoassay based on monoclonal antibodies in detection of influenza A and B viruses directly in clinical specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Effectiveness of influenza vaccine in health care professionals: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Comparative efficacy of inactivated and live attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Immunogenicity and Reactogenicity of 1 versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine‐Naive 5–8‐Year‐Old Children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Safety of the trivalent inactivated influenza vaccine among children: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970255-3

7 January 2021

10.1016/S1473-3099(10)70255-3

Identifiers

DOI

1 reference

19 September 2017

1 reference